Press release
Introduction of Hybrid Imaging Instruments Offering Enhanced Accuracy to Drive Growth of the Breast Cancer Diagnostics Market || Key Players: Biocept, Inc., Epigenomics AG, AstraZeneca plc, Myriad Genetics, Inc., and Quest Diagnostics Incorporated.
The global breast cancer diagnostics market has been witnessing a robust transformation on the back of several technological advancements in the diagnostic platforms. The market has witnessed the introduction of hybrid imaging instruments which offer an enhanced accuracy. These advancements have been augmenting growth of the global breast cancer diagnostics market. Increasing incidences of breast cancer and growth in older female population are expected to create lucrative growth opportunities for breast cancer diagnostics. In contrast, shortage of skilled and trained personnel is expected to pose a major challenge to the market growth of breast cancer diagnostics.
Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=55
The most common type of cancer for women across the globe currently is breast cancer. The number of breast cancer cases is expected to witness a rise, leading towards the requirement for efficient and early breast cancer detection. An established method, mammography, adopted in many countries, has recently been observed to provide inconclusive test results. Personalized and risk-adapted therapy are expected to resolve these difficulties. Tomosythesis, which has emerged as a new imaging technology, promises to overcome the challenges incurred in mammography.
The Fact.MR study provides comprehensive information about growth prospects of the Breas Cancer Diagnostics Market. The report covers the present ground scenario and future opportunity prospects for the market players to analyze the target markets across the globe. Moreover, the competitive analysis includes the in-depth analysis of the major players and leaders in virgin coconut oil industry.
Browse Full Report on Breast Cancer Diagnostics Market with TOC-
https://www.factmr.com/report/55/breast-cancer-diagnostics-market
The market study conducted on the basis of primary as well as secondary research where the analysts fragment the data from various databases such as Bloomberg, Factiva, Owler and others. Our primary research team conducted various interviews, surveys and group discussions of industry professionals,
Breast Cancer diagnostics market – Regional Overview & Competitive Backdrop A comprehensive section on the regional analysis of global breast cancer diagnostics market is included in the report. North America, Europe, Japan, Asia-Pacific excluding Japan (APEJ), Latin America, and Middle East & Africa are key regions into which the expansion of global breast cancer diagnostics market is studied. Developed markets with robust healthcare infrastructures are deemed lucrative for patients seeking diagnosis for breast cancer. On the other hand, higher resource availability, cheap wages, and lenient manufacturing regulations in developing regions attract the attention of manufacturers of breast cancer diagnosis instruments.
Key Players:
Roche Holding AG, Thermo Fischer Scientific, Inc., Siemens AG, Bio-Rad Laboratories, Inc., Illumina, Inc., Biocept, Inc., Epigenomics AG, AstraZeneca plc, Myriad Genetics, Inc., and Quest Diagnostics Incorporated.
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Introduction of Hybrid Imaging Instruments Offering Enhanced Accuracy to Drive Growth of the Breast Cancer Diagnostics Market || Key Players: Biocept, Inc., Epigenomics AG, AstraZeneca plc, Myriad Genetics, Inc., and Quest Diagnostics Incorporated. here
News-ID: 1697359 • Views: …
More Releases from Fact.MR
USB Wall Charger Market to Witness Exponential Growth, Expected to Hit US$ 3.09 …
As of 2023, the USB wall chargers market was valued at US$ 1.68 billion worldwide. By the end of 2033, the global market for USB wall chargers is expected to be valued US$ 3.09 billion, growing at a compound annual growth rate of 6.3%.
The rapid spread of the Internet throughout different locations is credited with creating growth potential in the global industry. It is also anticipated that the significant power…
Organic Fertilizer Market is Set to Hit US$ 16,673.5 Million at a CAGR of 6.4% b …
According to Fact.MR, the organic fertilizer market is anticipated to expand at a 6.4% CAGR between 2024 and 2034. The global market for these goods is anticipated to grow to US$ 16,673.5 million by 2034. Market research and competitive intelligence firm Fact MR states that the worldwide organic fertilizer market is expanding quickly and is predicted to maintain this development trajectory in the upcoming years.
The organic fertilizer industry can see…
Home Healthcare Market to Cross US$ 8,78,383.5 Million, Rising at a CAGR of 9.8% …
The global home healthcare industry is expected to be worth US$3,45,256.6 million in 2024. Through 2034, the market is expected to expand rapidly at a 9.8% CAGR. By 2034, the market is expected to grow to US$ 8,78,383.5 million.
There is an increasing need for in-home healthcare services as the number of senior people rises. Additionally, there is a growing need for the specialized care provided by home healthcare professionals due…
CAR T-Cell Therapy Market Size is Expected to Reach a Value of US$ 11.49 Billion …
The market for CAR T-cell treatment is expected to grow at an astounding 17.7% CAGR from 2024 to 2034, with a projected valuation of US$ 2.25 million in 2024.
Increased leukemia incidence, a surge in research and development to generate novel CAR T-cell therapy, and CAR T-cell therapy's better efficacy over other conventional cancer treatments are the main factors driving the market growth for CAR T-cell therapy.
𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
